Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Glucagon like peptide 1 (GLP-1) receptor agonists & Morbus Parkinson / Parkinson's Disease (PD)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Growth factors such as GLP-1 that can cross the BBB have already shown impressive effects in patients and are the future of drug discovery in PD.
Yang et al. 2022a Expert Opinion on Therapeutic Targets 26(5): 445-460

References (Sources)

Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson’s disease
Glotfelty et al. 2020 Exp Opin Inv Drugs 29: 595-602
Review
Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson’s disease
Yang et al. 2022a Expert Opinion on Therapeutic Targets 26(5): 445-460
Review

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Glucagon like peptide 1 (GLP-1) receptor agonists & Morbus Parkinson / Parkinson's Disease (PD)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat